The invention is directed to novel compounds of formulae (I), (II) and (III):
wherein X is O or NH;
R
3
is OH or a monosaccharide and R
4
is hydrogen, or R
3
is hydrogen and R
4
is OH or a monosaccharide;
R
5
is hydrogen or a monosaccharide; and pharmaceutically acceptable salts or esters thereof. The invention is also directed to the use of the compounds both directly and as immune adjuvants for treating cancer, infectious diseases and autoimmune diseases. The invention is also directed to syntheses of the intermediates which can be used to make these novel compounds.
该发明涉及以下化合物的新颖化合物:其中X为O或NH;R3为OH或
单糖,R4为氢,或R3为氢,R4为OH或
单糖;R5为氢或
单糖;以及其药用盐或酯。该发明还涉及这些化合物的直接使用以及作为免疫佐剂用于治疗癌症、传染病和自身免疫疾病。该发明还涉及合成这些中间体的方法,这些中间体可用于制备这些新颖化合物。